Efficacy and Safety of XT-150 in Osteoarthritis of the Knee
NCT04124042
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
289
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL:
XT-150
DRUG:
Placebo
Sponsor
Xalud Therapeutics, Inc.